Dyne Therapeutics, Inc. (DYN)

NASDAQ: DYN · Real-Time Price · USD

29.95

-0.04 (-0.13%)

Nov 21, 2024, 11:34 AM EST - Market open

Dyne Therapeutics Employees

Dyne Therapeutics had 141 employees as of December 31, 2023. The number of employees increased by 22 or 18.49% compared to the previous year.

Employees

141

Change (1Y)

22

Growth (1Y)

18.49%

Revenue / Employee

n/a

Profits / Employee

-$2,088,752

Market Cap

3.05B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	141	22	18.49%
Dec 31, 2022	119	26	27.96%
Dec 31, 2021	93	46	97.87%
Dec 31, 2020	47	-	-

Related Stocks

Company Name	Employees
Bausch Health Companies	20,270
Inari Medical	1,300
PTC Therapeutics	1,055
Veracyte	815
Agios Pharmaceuticals	386
Xenon Pharmaceuticals	259
Merus	229
Edgewise Therapeutics	88

Employee Rankings

DYN News

9 days ago - Dyne Therapeutics' Q3 Preview: High-Risk, High-Reward Path In Muscle Diseases - Seeking Alpha
13 days ago - Dyne Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
17 days ago - The Schall Law Firm Encourages Investor Participation In An Inquiry Into Dyne Therapeutics, Inc. For Possible Securities Law Violations - Accesswire
18 days ago - Dyne Therapeutics Inc Is Being Investigated For Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm - Accesswire
19 days ago - The Schall Law Firm Encourages Investor Participation In A Case Against Dyne Therapeutics, Inc. For Securities Law Violations - Accesswire
21 days ago - Dyne Therapeutics Inc Is Being Sued For Securities Fraud And Shareholders With Losses Are Urged To Contact The Schall Law Firm - Accesswire
22 days ago - The Schall Law Firm Encourages Investors To Join A Case Against Dyne Therapeutics, Inc. For Securities Law Violations - Accesswire
23 days ago - Dyne Therapeutics Inc May Have Committed Securities Fraud And Stockholders With Losses Are Urged To Reach Out To The Schall Law Firm - Accesswire